BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4611447)

  • 1. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels.
    Barry BW; Woodford R
    Br J Dermatol; 1974 Sep; 91(3):323-38. PubMed ID: 4611447
    [No Abstract]   [Full Text] [Related]  

  • 2. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial.
    Smith EB; Gregory JF; Bartruff JK
    South Med J; 1973 Mar; 66(3):325-9. PubMed ID: 4570656
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract]   [Full Text] [Related]  

  • 4. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)].
    Weirich EG; Lutz U
    Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215
    [No Abstract]   [Full Text] [Related]  

  • 5. Extemporaneous formulation of corticosteroids for topical usage.
    Burdick KH; Poulsen B; Place VA
    JAMA; 1970 Jan; 211(3):462-6. PubMed ID: 5466919
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability of topical steroids.
    Barry BW
    Dermatologica; 1976; 152 Suppl 1():47-65. PubMed ID: 955238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
    Coldman MF; Lockerbie L; Laws EA
    Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552
    [No Abstract]   [Full Text] [Related]  

  • 8. Corticosteroid ointments: comparison by two human bioassays.
    Burdick KH; Haleblian JK; Poulsen BJ; Cobner SE
    Curr Ther Res Clin Exp; 1973 May; 15(5):233-42. PubMed ID: 4196783
    [No Abstract]   [Full Text] [Related]  

  • 9. Objective measurement of topically applied corticosteroids.
    Király K; Soós G
    Dermatologica; 1976; 152 Suppl 1():133-7. PubMed ID: 955233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of corticosteroids, griseofulvin and tolnaftate on the in vitro growth of two dermatophytes.
    Caplan RM; Clabaugh W
    J Invest Dermatol; 1969 Mar; 52(3):247-54. PubMed ID: 5774352
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig.
    Winter GD; Wilson L
    Br J Dermatol; 1976 May; 94(5):545-50. PubMed ID: 1268065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the effectiveness of locally administered corticosteroids].
    Semrádová V; Horácek J
    Cesk Dermatol; 1974 Jul; 49(4):222-6. PubMed ID: 4844681
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical assessment of topical corticosteroid activity.
    Wilson L
    Br J Dermatol; 1976 Mar; 94 suppl 12():33-42. PubMed ID: 773412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoconstrictor and systemic activities of topical steroids.
    Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA
    Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenocortical suppression with small doses of topical corticosteroids.
    Carr RD; Belcher RW
    Acta Derm Venereol; 1969; 49(5):508-13. PubMed ID: 4186337
    [No Abstract]   [Full Text] [Related]  

  • 16. [TREATMENT OF PSORIASIS WITH WET OCCLUSIVE DRESSING].
    KONIA H
    Dermatologica; 1964; 129():47-56. PubMed ID: 14181377
    [No Abstract]   [Full Text] [Related]  

  • 17. Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid.
    Bluefarb SM; Howard FM; Leibsohn E; Schlagel CA; Wexler L
    J Int Med Res; 1976; 4(6):454-61. PubMed ID: 800385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bio-assay of corticosteroids for topical application.
    Spearman RI; Jarrett A
    Br J Dermatol; 1975 May; 92(5):581-4. PubMed ID: 1174471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative blanching activities of proprietary diflucortolone valerate topical preparations.
    Coleman GL; Kanfer I; Haigh JM
    Dermatologica; 1978; 156(4):224-30. PubMed ID: 342295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and activity of betamethasone 17-benzoate in gel and cream formulations: comparison with proprietary topical corticosteroid preparations in the vasoconstrictor assay.
    Woodford R; Barry BW
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):338-45. PubMed ID: 4208350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.